Jane Street Group, LLC Axonics, Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$43.74 - $62.76 $192,456 - $276,144	4,400 Added 16.3%	31,400 $1.97 Million
Q4 2021 Feb 15, 2022	BUY	$50.01 - $73.35 $1.14 Million - $1.67 Million	22,700 Added 527.91%	27,000 $1.51 Million
Q3 2021 Nov 16, 2021	SELL	$59.21 - $78.66 $532,890 - $707,940	-9,000 Reduced 67.67%	4,300 $280,000
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $154,170 - $200,700	-3,000 Reduced 18.4%	13,300 $843,000
Q1 2021 May 18, 2021	BUY	$49.14 - $59.89 $471,744 - $574,944	9,600 Added 143.28%	16,300 $976,000
Q4 2020 Feb 17, 2021	SELL	$42.19 - $51.5 $898,647 - $1.1 Million	-21,300 Reduced 76.07%	6,700 $334,000
Q3 2020 Nov 17, 2020	BUY	$35.33 - $51.04 $989,240 - $1.43 Million	28,000 New	28,000 $1.43 Million

230

42.9M

50.2K

165K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.46B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.